Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP477213.RAocPwJ0ZLchpppHHIU1rE3uG0jvKq9eT4o8VnRYvju8I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP477213.RAocPwJ0ZLchpppHHIU1rE3uG0jvKq9eT4o8VnRYvju8I130_assertion type Assertion NP477213.RAocPwJ0ZLchpppHHIU1rE3uG0jvKq9eT4o8VnRYvju8I130_head.
- NP477213.RAocPwJ0ZLchpppHHIU1rE3uG0jvKq9eT4o8VnRYvju8I130_assertion description "[Measures of expression of the M2 cell markers CD14, CD68, CD163, and CD204, which are elevated in high-grade gliomas, and the neutrophil/myeloid-derived suppressor cell (MDSC) subset marker CD15, which is reduced, provide the best index of glioma grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477213.RAocPwJ0ZLchpppHHIU1rE3uG0jvKq9eT4o8VnRYvju8I130_provenance.
- NP477213.RAocPwJ0ZLchpppHHIU1rE3uG0jvKq9eT4o8VnRYvju8I130_assertion evidence source_evidence_literature NP477213.RAocPwJ0ZLchpppHHIU1rE3uG0jvKq9eT4o8VnRYvju8I130_provenance.
- NP477213.RAocPwJ0ZLchpppHHIU1rE3uG0jvKq9eT4o8VnRYvju8I130_assertion SIO_000772 23741072 NP477213.RAocPwJ0ZLchpppHHIU1rE3uG0jvKq9eT4o8VnRYvju8I130_provenance.
- NP477213.RAocPwJ0ZLchpppHHIU1rE3uG0jvKq9eT4o8VnRYvju8I130_assertion wasDerivedFrom befree-20140225 NP477213.RAocPwJ0ZLchpppHHIU1rE3uG0jvKq9eT4o8VnRYvju8I130_provenance.
- NP477213.RAocPwJ0ZLchpppHHIU1rE3uG0jvKq9eT4o8VnRYvju8I130_assertion wasGeneratedBy ECO_0000203 NP477213.RAocPwJ0ZLchpppHHIU1rE3uG0jvKq9eT4o8VnRYvju8I130_provenance.